Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate USANA Health Sciences, Inc. before investing.

In this article, we go over a few key elements for understanding USANA Health Sciences, Inc.’s stock price such as:

• USANA Health Sciences, Inc.’s current stock price and volume
• Why USANA Health Sciences, Inc.’s stock price changed recently
• Upgrades and downgrades for USNA from analysts
• USNA’s stock price momentum as measured by its relative strength

About USANA Health Sciences, Inc. (USNA)

Before we jump into USANA Health Sciences, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Want to learn more about USANA Health Sciences, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about USANA Health Sciences, Inc..

USANA Health Sciences, Inc.’s Stock Price as of Market Close

As of February 19, 2026, 4:00 PM, CST, USANA Health Sciences, Inc.’s stock price was $20.550.

USANA Health Sciences, Inc. is up 8.16% from its previous closing price of $19.000.

During the last market session, USANA Health Sciences, Inc.’s stock traded between $18.980 and $20.800. Currently, there are approximately 18.29 million shares outstanding for USANA Health Sciences, Inc..

USANA Health Sciences, Inc.’s price-earnings (P/E) ratio is currently at 22.9, which is high compared to the Personal Care Products industry median of 21. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

USANA Health Sciences, Inc. Stock Price History

USANA Health Sciences, Inc.’s (USNA) price is currently down 5.3% so far this month.

During the month of February, USANA Health Sciences, Inc.’s stock price has reached a high of $22.520 and a low of $18.570.

Over the last year, USANA Health Sciences, Inc. has hit prices as high as $38.320 and as low as $18.480. Year to date, USANA Health Sciences, Inc.’s stock is up 4.69%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused USANA Health Sciences, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of February 19, 2026, there was 1 analyst who downgraded USANA Health Sciences, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate USANA Health Sciences, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on USANA Health Sciences, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

USANA Health Sciences, Inc.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about USANA Health Sciences, Inc. (USNA) by visiting AAII Stock Evaluator.

Relative Price Strength of USANA Health Sciences, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of February 19, 2026, USANA Health Sciences, Inc. has a weighted four-quarter relative price strength of -6.92%, which translates to a Momentum Score of 27 and is considered to be Weak.

Want to learn more about how USANA Health Sciences, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

USANA Health Sciences, Inc. Stock Price: Bottom Line

As of February 19, 2026, USANA Health Sciences, Inc.’s stock price is $20.550, which is up 8.16% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like USANA Health Sciences, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.